Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Streamex ( (STEX) ) has provided an announcement.
Streamex Corp. has amended its Secured Convertible Debenture Purchase Agreement with Yorkville, a Cayman Islands exempt limited company, to secure up to $100 million through convertible debentures. The recent amendment on October 28, 2025, mandates that $25.1 million be allocated for purchasing Allocated Vaulted Gold Bullion, with strict compliance required under a Guaranty and Security Agreement. The agreement involves a first priority security interest in the company’s assets and includes conditions such as Nasdaq approval. The first convertible debenture, valued at $25 million, will mature in 24 months with a 4% interest rate, increasing to 18% upon default.
The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.
Spark’s Take on STEX Stock
According to Spark, TipRanks’ AI Analyst, STEX is a Underperform.
BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.
To see Spark’s full report on STEX stock, click here.
More about Streamex
Average Trading Volume: 1,156,061
Technical Sentiment Signal: Hold
Current Market Cap: $166.8M
See more data about STEX stock on TipRanks’ Stock Analysis page.